original ) (raw )Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2
John Yannelli
Cancer research, 1990
View PDFchevron_right
Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
Sergio Rutella
Journal of Translational Medicine, 2010
View PDFchevron_right
Growth of Murine Natural-Killer-Cells from Bone-Marrow Invitro - Role of TNF-Alpha and Ifn-Gamma
Carlo Riccardi
International Journal of Immunopharmacology, 1991
View PDFchevron_right
Thymoglobulin, interferon-g and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures
daniela fioravanti
J Transl Med, 2010
View PDFchevron_right
Effect of interleukin-4 on interleukin-2-dependent generation of natural killer cells
Carlo Riccardi
Cellular Immunology, 1991
View PDFchevron_right
In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro
Marijke Bleumink
Cellular Immunology, 1991
View PDFchevron_right
Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy
Eric Bluman
Journal of Clinical Investigation, 2000
View PDFchevron_right
Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes
Prof.dr.REINDER LH BOLHUIS
Cancer research, 1991
View PDFchevron_right
Addition of interleukin-2in vitro augments detection of lymphokine-activated killer activity generatedin vivo
Jacquelyn Hank
Cancer Immunology Immunotherapy, 1990
View PDFchevron_right
Recombinant interleukin 2 rapidly augments human natural killer cell activity
Hermann Wagner
Cellular Immunology, 1985
View PDFchevron_right
Interleukin-2 apparently upregulates its receptor and induces proliferation of various resting mononuclear leukocytes in the absence of antigen
Mario Abbud-Filho
Cellular Immunology, 1985
View PDFchevron_right
Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2
Yael Kaufmann
Cancer research, 1984
View PDFchevron_right
Response of resting human peripheral blood natural killer cells to interleukin 2
Jasbir Seehra
Journal of Experimental Medicine, 1984
View PDFchevron_right
Modulation of human natural killer cell activity by recombinant human interleukin 2
R. Bleackley
Cellular Immunology, 1985
View PDFchevron_right
Lymphokine activated killer cells
Roland Mertelsmann
Blut, 1989
View PDFchevron_right
Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen
Dan Longo
PubMed, 1990
View PDFchevron_right
Lymphokine-activated Killer Cells in Rats: Analysis of Tissue and Strain Distribution, Ontogeny, and Target Specificity1
Nikola Vujanovic
2000
View PDFchevron_right
Functional studies on the precursors of human lymphokine-activated killer cells
Sidney Golub
Cellular Immunology, 1985
View PDFchevron_right
Population dynamics of human activated natural killer cells in culture
Bryce Pierson
Biotechnology and Bioengineering, 1994
View PDFchevron_right
Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response
Yahya Zaloom
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Interleukin-2 activated human killer lymphocytes: Lack of involvement of interferon in the development of IL-2-activated killer lymphocytes
Nitin Damle
International Journal of Cancer, 1987
View PDFchevron_right
Lymphokine-activated killer cells in rats: Generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells
Nikola Vujanovic
Cellular Immunology, 1989
View PDFchevron_right
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures
Robert Kastelein
Journal of Immunology, 1988
View PDFchevron_right
Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in rim
Dan Longo
Blood
View PDFchevron_right
Interleukin2Activated Natural Killer Cells Can Support Hematopoiesis In Vitro and Promote Marrow Engraftment In Vivo
Dan Longo
1992
View PDFchevron_right
An improved method for the generation of human lymphokine activated killer cells
John Yannelli
Journal of Immunological Methods, 1987
View PDFchevron_right
Low doses of interferon alpha result in more effective clinical natural killer cell activation
Robert Fuhlbrigge
Journal of Clinical Investigation, 1985
View PDFchevron_right
Stable Transduction of the Interleukin-2 Gene Into Human Natural Killer Cell Lines and Their Phenotypic and Functional Characterization In Vitro and In Vivo
Robbie Mailliard
Blood, 1998
View PDFchevron_right
Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans
John Mannick
Cancer Immunology Immunotherapy, 1989
View PDFchevron_right
Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice
Masayuki Miyasaka
The Journal of experimental medicine, 1993
View PDFchevron_right
In vitro modulation of human natural killer cell activity by interferon: Generation of adherent suppressor cells
M. Micksche
British Journal of Cancer, 1984
View PDFchevron_right
Induction of lymphokine-activated killer activity in rat splenocyte cultures: The importance of 2-mercaptoethanol and indomethacin
Emile Heer
Cancer Immunology Immunotherapy, 1991
View PDFchevron_right
SYNERGISTIC PROLIFERATION AND ACTIVATION OF NATURAL KILLER CELLS BY INTERLEUKIN 12 AND INTERLEUKIN 18
Jean-christophe Renauld
Cytokine, 1999
View PDFchevron_right
Studies of serum-free medium for the generation of lymphokine-activated killer cells
Kosei Yasumoto
Cytotechnology, 1991
View PDFchevron_right
Generation of natural killer cells and lymphokine-activated killer cells in human AB serum or fetal bovine serum
Turgut Imir
Clinical Immunology and Immunopathology, 1985
View PDFchevron_right